rs7848919

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000638233.1(GLDC):​n.2038C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.707 in 154,584 control chromosomes in the GnomAD database, including 38,956 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 38283 hom., cov: 29)
Exomes 𝑓: 0.63 ( 673 hom. )

Consequence

GLDC
ENST00000638233.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.693

Publications

14 publications found
Variant links:
Genes affected
GLDC (HGNC:4313): (glycine decarboxylase) Degradation of glycine is brought about by the glycine cleavage system, which is composed of four mitochondrial protein components: P protein (a pyridoxal phosphate-dependent glycine decarboxylase), H protein (a lipoic acid-containing protein), T protein (a tetrahydrofolate-requiring enzyme), and L protein (a lipoamide dehydrogenase). The protein encoded by this gene is the P protein, which binds to glycine and enables the methylamine group from glycine to be transferred to the T protein. Defects in this gene are a cause of nonketotic hyperglycinemia (NKH).[provided by RefSeq, Jan 2010]
GLDC Gene-Disease associations (from GenCC):
  • glycine encephalopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Labcorp Genetics (formerly Invitae), ClinGen
  • glycine encephalopathy 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • infantile glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • neonatal glycine encephalopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atypical glycine encephalopathy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-6532477-G-A is Benign according to our data. Variant chr9-6532477-G-A is described in ClinVar as Benign. ClinVar VariationId is 367162.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.948 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLDCNM_000170.3 linkc.*540C>T 3_prime_UTR_variant Exon 25 of 25 ENST00000321612.8 NP_000161.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLDCENST00000321612.8 linkc.*540C>T 3_prime_UTR_variant Exon 25 of 25 1 NM_000170.3 ENSP00000370737.4

Frequencies

GnomAD3 genomes
AF:
0.708
AC:
107145
AN:
151230
Hom.:
38254
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.700
Gnomad AMI
AF:
0.451
Gnomad AMR
AF:
0.756
Gnomad ASJ
AF:
0.673
Gnomad EAS
AF:
0.971
Gnomad SAS
AF:
0.722
Gnomad FIN
AF:
0.765
Gnomad MID
AF:
0.712
Gnomad NFE
AF:
0.680
Gnomad OTH
AF:
0.680
GnomAD4 exome
AF:
0.629
AC:
2041
AN:
3246
Hom.:
673
Cov.:
0
AF XY:
0.628
AC XY:
1092
AN XY:
1738
show subpopulations
African (AFR)
AF:
0.250
AC:
1
AN:
4
American (AMR)
AF:
0.716
AC:
388
AN:
542
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
2
AN:
8
East Asian (EAS)
AF:
1.00
AC:
32
AN:
32
South Asian (SAS)
AF:
0.579
AC:
161
AN:
278
European-Finnish (FIN)
AF:
0.725
AC:
309
AN:
426
Middle Eastern (MID)
AF:
0.500
AC:
1
AN:
2
European-Non Finnish (NFE)
AF:
0.585
AC:
1093
AN:
1868
Other (OTH)
AF:
0.628
AC:
54
AN:
86
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
33
66
98
131
164
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.709
AC:
107227
AN:
151338
Hom.:
38283
Cov.:
29
AF XY:
0.715
AC XY:
52828
AN XY:
73900
show subpopulations
African (AFR)
AF:
0.700
AC:
28790
AN:
41152
American (AMR)
AF:
0.756
AC:
11522
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.673
AC:
2334
AN:
3466
East Asian (EAS)
AF:
0.971
AC:
5007
AN:
5158
South Asian (SAS)
AF:
0.722
AC:
3453
AN:
4784
European-Finnish (FIN)
AF:
0.765
AC:
7954
AN:
10396
Middle Eastern (MID)
AF:
0.714
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
0.680
AC:
46127
AN:
67856
Other (OTH)
AF:
0.680
AC:
1420
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
1577
3154
4731
6308
7885
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.688
Hom.:
122638
Bravo
AF:
0.706
Asia WGS
AF:
0.826
AC:
2873
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycine encephalopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
4.2
DANN
Benign
0.62
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7848919; hg19: chr9-6532477; API